Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells

J Immunol. 1996 Sep 1;157(5):1878-85.

Abstract

CD40 ligand-activated B cells are sensitive targets for CD4+ Th1 effector cells that kill in a Fas-dependent fashion. Susceptibility to apoptosis is counteracted by Ag receptor binding that produces a state of resistance to Fas engagement in otherwise sensitive targets. In the present study, protection from Th1-mediated apoptosis was found to be induced by protein kinase C and calcium signals, which in combination mimicked the level of Fas resistance produced by surface Ig engagement. Signaling for Fas resistance did not alter Fas expression. Furthermore, B cells that were protected against Th1-mediated apoptosis were also resistant to apoptosis mediated by soluble, rFas ligand. Taken together, these results indicate that signaling for protection against Fas-mediated apoptosis does not depend on alteration of the interaction between B cell target and Th1 effector populations. Instead, surface IgM-derived protein kinase C and calcium signals appear to produce an intracellular change in the Fas signaling pathway that develops over a period of hours and interferes with the apoptotic process through a mechanism that depends on protein synthesis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Anti-Idiotypic / pharmacology
  • Apoptosis / drug effects
  • Apoptosis / immunology*
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism*
  • Cytotoxicity, Immunologic / drug effects
  • Drug Combinations
  • Immunoglobulin M / immunology
  • Intracellular Fluid / immunology
  • Ionomycin / pharmacology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Protein Biosynthesis
  • Protein Kinase C / physiology
  • Receptors, Antigen, B-Cell / biosynthesis*
  • Receptors, Antigen, B-Cell / drug effects
  • Receptors, Antigen, B-Cell / immunology*
  • Signal Transduction / drug effects
  • Signal Transduction / immunology*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Th1 Cells / enzymology
  • Th1 Cells / immunology
  • fas Receptor / biosynthesis
  • fas Receptor / drug effects
  • fas Receptor / immunology*

Substances

  • Antibodies, Anti-Idiotypic
  • Drug Combinations
  • Immunoglobulin M
  • Receptors, Antigen, B-Cell
  • anti-IgM
  • fas Receptor
  • Ionomycin
  • Protein Kinase C
  • Tetradecanoylphorbol Acetate